New York 2025-2026 Regular Session

New York Senate Bill S00488

Introduced
1/8/25  
Refer
1/8/25  
Engrossed
2/25/25  
Refer
2/25/25  
Engrossed
6/9/25  
Refer
6/9/25  
Refer
1/7/26  
Report Pass
1/28/26  
Report Pass
5/12/26  
Engrossed
5/12/26  

Caption

Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

Companion Bills

NY A02289

Same As Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

Previously Filed As

NY A02289

Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

NY A09248

Enacts the New York state pharmaceutical drug manufacturer and wholesaler disclosure act; requires pharmaceutical drug manufacturers and wholesalers to annually report to the New York department of health, for disclosure to the general public, all of its gifts to health care practitioners that prescribe drugs when such gifts have a value of seventy-five dollars or more; authorizes the commissioner of health to impose penalties and promulgate necessary rules and regulations.

NY HB772

AN ACT relating to pharmaceutical manufacturers.

NY HB3086

Relating to requirements for pharmaceutical drug manufacturers to report prescription drug costs.

NY SB14

AN ACT relating to pharmaceutical manufacturers.

NY SF3650

Manufacturers prohibited from advertising prescription drugs on television

NY HB1531

To Prohibit Pharmaceutical Manufacturers From Restricting Or Limiting Prescription Medications To A Limited Distribution Network Of Out-of-state Pharmacies.

NY SB2024

Pharmaceutical products; requiring publishing of certain information by manufacturers. Effective date.

NY S09153

Adds parcels of land to the list of premises which are exempt from the provisions of law which generally restrict manufacturers/wholesalers and retailers from sharing an interest in a liquor license.

NY HF4124

Manufacturers prohibited from advertising prescription drugs on television.

Similar Bills

SC H3728

Vapor Products

SC S0287

Electronic Nicotine Delivery System Regulation

PA HB1425

An act amending the act of April 9, 1929 (P.L.343, No.176), known as The Fiscal Code, in cigarette sales and licensing, further providing for definitions and providing for presumed cost of doing business by retailer; providing for tobacco products; and making repeals.

MD HB870

Tobacco Product Manufacturers - Escrow Act - Alterations

NJ A4184

Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

MA S1019

Relative to manufactured housing communities

CO SB322

Management of Consumer Protection Claims Critical Infrastructure

PA HB386

Providing for an index relating to diagnosis, maintenance and repair of digital electronic equipment and for enforcement by Attorney General.